|
»ç¶÷ÀÎHR |
[ÇìµåÇåÆÃ] ¿Ü±¹°è À¯¸í ÀÇ·á±â±â RA&QA ´ã´ç ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
11.06 |
|
|
Ä¿¸®¾îÄɾî |
±Û·Î¹úÁ¦¾àȸ»ç RA manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
6³â¡è |
ä¿ë½Ã |
08.28 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Sr.RA Specialist & RA Specialist/¹Ì±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
09.03 |
|
|
(ÁÖ)¿¡ÀÌÄ¡¾Ë±×·ì |
º¥Ã³ ÀÇ·á±â±âȸ»ç RA ½Ç¹«ÀÚ±Þ
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
3³â¡è |
»ó½Ãä¿ë |
07.29 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
RA ÆÀÀå(Â÷ºÎÀå±Þ)/¿Ü±¹°èÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
01.13 |
|
|
(ÁÖ)Ä¿¸®¾îºôµå |
Glabal BD Manager - ÀÓ»óÀü¹®±â¾÷
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
9³â¡è |
ä¿ë½Ã |
07.03 |
|
|
(ÁÖ)Ä¿¸®¾îºôµå |
Regulatory Affairs-Health Care MNC
¼¿ï ¿µµîÆ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
07.03 |
|
|
(ÁÖ)Ä¿¸®¾îºôµå |
´ë±â¾÷ °³¹ßÆÀÀå ¸ðÁýÇÕ´Ï´Ù.
°æ±â ¼ö¿ø½Ã ±Ç¼±±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
10³â¡è |
ä¿ë½Ã |
07.03 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀå´ë±â¾÷ BD °æ·ÂÀÚ ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.10 |
|
|
±¹³» »óÀ§Á¦¾à»ç |
±¹³» »óÀ§Á¦¾à»ç °³¹ß°£ºÎ »ç¿ø ¸ðÁý
¼¿ï ¼´ë¹®±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
10³â¡è |
ä¿ë½Ã |
05.31 |
|
|
»ç¶÷ÀÎHR |
±Û·Î¹ú¹ÙÀÌ¿À±â¾÷ CMC(Chemistry, Manufacture & Control)
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
»ó½Ãä¿ë |
05.21 |
|
|
Ä¿¸®¾îÄɾî |
±Û·Î¹ú ÀÇ·áÀåºñ±â¾÷ FDA ÀÎÇã°¡
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
05.10 |
|
|
³ª¿ìÆÊÄÁ¼³Æà |
»óÀåÁ¦¾à»ç °³¹ßºÎ °£ºÎ ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.09 |
|
|
Ä¿¸®¾îÄɾî |
±×·ì»ç ¹ÙÀÌ¿ÀÀǾàÇ° Çã°¡ ´ã´ç
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
05.02 |
|
|
Ä¿¸®¾îÄɾî |
¿Ü±¹°èÁ¦¾à»ç RA (´ë°ü)Associate~Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
04.10 |
|